Skip to content

Bone Alkaline Phosphatase (B-ALP) Test: Measuring Your Bone Health with a Simple Blood Test

Published: July 31, 2026Updated: August 10, 2026

The bone alkaline phosphatase test measures the amount of an enzyme made specifically by bone-forming cells in your blood, helping your doctor evaluate your bone health and detect or monitor bone disorders.

Quick summary

{"Bone alkaline phosphatase (B-ALP) is a marker of bone formation produced by osteoblasts","Elevated levels may indicate bone diseases such as Paget's disease, osteoporosis, or bone cancer","The test helps distinguish between bone and liver causes of elevated alkaline phosphatase","It is commonly used to monitor treatment effectiveness for bone disorders","A simple blood test is all that is needed; no special preparation is typically required"}

Medically reviewed by WellAlly Editorial TeamLast reviewed August 10, 2026Editorial policy

Key facts at a glance

LOINC
1777-2
Short code
B-ALP, Bone ALP, Bone-specific ALP
Synonyms
ALP Bone SerPl-cCnc
Category
chemistry
Sample
serum
Container
Serum separator tube (SST/Gel tube) or plain red top tube
Units
not specified
Ref low
15
Ref high
41.3
Fasting
false
Population
adult
Sex
all
Age range
≥ 0 years
Method
Enzymatic assay using p-nitrophenylphosphate (pNPP) substrate with detection at 405 nm, following IFCC recommended procedure
CPT
84075 (Alkaline phosphatase, total isoenzyme) or 82150 (Alkaline phosphatase, isoenzyme analysis)
SNOMED
275136008 (Alkaline phosphatase measurement)
Specimen volume
1.0-2.0 mL serum minimum
Stability
Room temperature: 7 days; Refrigerated (2-8°C): 7-14 days; Frozen (-20°C or below): 30 days. Avoid repeated freeze-thaw cycles
Hemolysis max
50
Lipemia max
300
Icterus max
20
TAT
1–48 hours
Order
routine

What is this test?

The bone alkaline phosphatase (B-ALP) test measures the level of a specific type of alkaline phosphatase enzyme that comes from bone-forming cells called osteoblasts. While total alkaline phosphatase (ALP) can come from both liver and bone sources, this test specifically targets the bone-derived portion, giving your doctor more precise information about your bone health.

Why is this test performed?

Your doctor may order a bone ALP test to: evaluate bone disorders such as Paget's disease, osteomalacia, or rickets; monitor bone health in conditions that affect bone metabolism; distinguish between bone and liver disease when alkaline phosphatase is elevated; assess the effectiveness of treatments for bone diseases; and check for bone metastases or bone cancer.

How is the test performed?

A healthcare professional will draw a small blood sample from a vein in your arm. The sample is then sent to a laboratory for analysis. The procedure is quick and generally causes minimal discomfort. You may be asked to fast for several hours before the test, so follow your doctor's instructions carefully.

What do the results mean?

Elevated bone alkaline phosphatase levels may indicate increased bone turnover or bone formation activity, which can occur in conditions like Paget's disease (where bone breakdown and formation are abnormally rapid), osteoporosis, bone metastases, osteomalacia, rickets, or after bone fractures. Normal or low levels typically indicate healthy bone metabolism, though interpretation should always be done by your healthcare provider who will consider your overall health, symptoms, and other test results.

Reference range

15.0-41.3 U/L (adult males); 11.6-29.6 U/L (premenopausal females); 14.2-42.7 U/L (postmenopausal females)not specified

Specimen: serum

No fasting or special preparation required; discontinue biotin supplements 72 hours prior if using immunoassay method

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Bone alkaline phosphatase serves as a reliable marker of bone formation activity. In Paget's disease, B-ALP levels are often significantly elevated and correlate with disease activity, making it useful for diagnosis and monitoring treatment response. In osteoporosis, moderately elevated levels may indicate increased bone turnover, which can help guide treatment decisions.

When combined with other markers like urine N-telopeptide or CTX (C-terminal telopeptide), B-ALP helps provide a complete picture of bone metabolism—both formation and breakdown. This is particularly valuable in postmenopausal women and men on osteoporosis therapy, where monitoring both sides of bone remodeling helps assess whether treatment is working effectively.

The test is also important in distinguishing the source of elevated total alkaline phosphatase. If both total ALP and bone-specific ALP are elevated, bone disease is likely. If only total ALP is elevated with normal bone ALP, the issue is more likely liver-related, guiding further diagnostic steps.

Frequently asked questions

Do I need to fast before the bone alkaline phosphatase test?
Fasting is typically not required for the bone ALP test, but your doctor may ask you to fast if other blood tests are being done at the same time. Always follow the specific instructions provided by your healthcare provider.
How is bone ALP different from total alkaline phosphatase?
Total alkaline phosphatase (ALP) is an enzyme found in various tissues, including liver, bone, intestines, and kidneys. The bone alkaline phosphatase test specifically measures the portion of ALP that comes from bone-forming cells (osteoblasts), providing more targeted information about bone health rather than general tissue damage.
What conditions cause high bone alkaline phosphatase levels?
High B-ALP levels can be caused by Paget's disease, bone metastases or primary bone cancer, osteomalacia (vitamin D deficiency), rickets, hyperparathyroidism (overactive parathyroid glands), recent bone fractures, or certain medications that affect bone metabolism. Growing children naturally have higher levels due to bone growth.
Is the bone ALP test used to monitor osteoporosis treatment?
Yes, bone alkaline phosphatase is commonly used as a biochemical marker to monitor the effectiveness of osteoporosis treatments, particularly bisphosphonates and other anti-resorptive therapies. A decreasing B-ALP level over time generally indicates that treatment is successfully reducing bone turnover.
Are there any risks associated with this test?
The risks are minimal and similar to any standard blood draw. These may include slight pain or bruising at the puncture site, dizziness, or in rare cases, infection. The benefits of obtaining important diagnostic information far outweigh these minimal risks.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 10, 2026. · Read our editorial policy